Thermo Fisher

Executive Summary

Thermo Fisher Scientific is a global leader in serving science, enabling customers to make the world healthier, cleaner, and safer. The company offers a comprehensive portfolio of technology, pharmaceutical services, and biotechnology solutions, with a strong emphasis on antibodies and diagnostics. Its products are critical for research, diagnostics, and manufacturing across life sciences and healthcare. Founded in 1956 and headquartered in Oslo, Norway, Thermo Fisher is a privately held entity with an estimated valuation of $182.6 billion as of early 2026. The company's extensive catalog includes high-quality antibodies and diagnostic tools that support diverse applications from basic research to clinical diagnostics. With a focus on innovation and customer success, Thermo Fisher continues to expand its reach through strategic acquisitions and organic growth, solidifying its position as an essential partner in the scientific community.

Upcoming Catalysts (preview)

• Q4 2026Launch of Next-Generation Antibody Discovery Platform70% success
• TBDExpansion into Point-of-Care Diagnostics Market60% success
• Q2 2026Strategic Partnership for CRISPR-Based Diagnostics50% success